Fatal coronary artery disease in an infant with severe mucopolysaccharidosis type I

Pediatrics

Volumn 127, Issue 5, 2011, Pages

  Van Den Broek, Leonie ^a   Backx, Ad P C M ^b   Coolen, Hans ^c   Wijburg, Frits A ^b   Wevers, Ron ^c   Morava, Eva ^c   Neeleman, Chris ^c  

^a CATHARINA HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bone marrow transplantation; Enzyme replacement therapy; Heart failure; Mucopolysaccharidosis type I (Hurler syndrome)

Indexed keywords

GLYCOSAMINOGLYCAN; LEVO IDURONIDASE;

ANGIOCARDIOGRAPHY; ARTICLE; BODY SIZE; BREATHING; CARDIOMEGALY; CASE REPORT; CHILD; COARSE FACE; COLLATERAL CIRCULATION; CORONARY ARTERY DISEASE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ENZYME REPLACEMENT; FATALITY; HEART FAILURE; HEART LEFT VENTRICLE WALL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HURLER SYNDROME; HYPERTROPHIC CARDIOMYOPATHY; INFANT; LEUKOCYTE; LYSOSOME STORAGE DISEASE; MALE; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RIGHT CORONARY ARTERY; THORAX RADIOGRAPHY; URINE LEVEL;

CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DISEASE PROGRESSION; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FATAL OUTCOME; HEART FAILURE; HUMANS; INFANT; MALE; MUCOPOLYSACCHARIDOSIS I; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 79955501783     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2009-2047     Document Type: Article

References (9)

1. Braunlin EA, Berry JM, Whitley CB. Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type 1. Am J Cardiol. 2006;98(3):416-418 (Pubitemid 44062452)
2. Bjoraker KJ, Delaney K, Peters C, Krivit W, Shapiro EG. Long-term outcomes of adaptive functions for children with mucopolysaccharidosis I (Hurler syndrome) treated with hematopoietic stem cell transplantation. J Dev Behav Pediatr. 2006;27(4): 290-296 (Pubitemid 44231667)
3. Braunlin EA, Stauffer NR, Peters CH, et al. Usefulness of bone marrow transplantation in the Hurler syndrome. Am J Cardiol. 2003; 92(7):882-886 (Pubitemid 37163595)
4. Sifuentes M, Doroshow R, Hoft R, et al. A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years. Mol Genet Metab. 2007;90(2): 171-180 (Pubitemid 46108607)
5. Braunlin EA, Rose AG, Hopwood JJ, Candel RD, Krivit W. Coronary artery patency following long-term successful engraftment 14 years after bone marrow transplantation in the Hurler syndrome. Am J Cardiol. 2001;88(9): 1075-1077 (Pubitemid 33042633)
6. Breider MA, Shull RM, Constantopoulos G. Long-term effects of bone marrow transplantation in dogs with mucopolysaccharidosis I. Am J Pathol. 1989;134(3):677-692 (Pubitemid 19082862)
7. Braunlin EA, Hunter DW, Krivit W, et al. Evaluation of coronary artery disease in the Hurler syndrome by angiography. Am J Cardiol. 1992;69(17):1487-1489
8. Scott HS, Bunge S, Gal A, Clarke LA, Morris CP, Hopwood JJ. Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications. Hum Mutat. 1995;6(4):288-302
9. Vazna A, Beesley C, Berna L, et al. Mucopolysaccharidosis type I in 21 Czech and Slovak patients: mutation analysis suggests a functional importance of C-terminus of the IDUA protein. Am J Med Genet A. 2009;149A(5): 965-974